{"id":"https://openalex.org/W2139132107","doi":"https://doi.org/10.1111/j.1742-7843.2004.pto950509.x","title":"Adenosine A1 Receptor Blockade Mimics Caffeine's Attenuation of Ethanol\u2010Induced Motor Incoordination","display_name":"Adenosine A1 Receptor Blockade Mimics Caffeine's Attenuation of Ethanol\u2010Induced Motor Incoordination","publication_year":2004,"publication_date":"2004-11-29","ids":{"openalex":"https://openalex.org/W2139132107","doi":"https://doi.org/10.1111/j.1742-7843.2004.pto950509.x","mag":"2139132107","pmid":"https://pubmed.ncbi.nlm.nih.gov/15569276"},"language":"en","primary_location":{"id":"doi:10.1111/j.1742-7843.2004.pto950509.x","doi":"https://doi.org/10.1111/j.1742-7843.2004.pto950509.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1742-7843.2004.pto950509.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-7843.2004.pto950509.x","source":{"id":"https://openalex.org/S44074210","display_name":"Basic & Clinical Pharmacology & Toxicology","issn_l":"1742-7835","issn":["1742-7835","1742-7843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Basic &amp; Clinical Pharmacology &amp; Toxicology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-7843.2004.pto950509.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091531703","display_name":"Laura Connole","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Laura Connole","raw_affiliation_strings":["Department of Safety Pharmacology, H. Lundbeck A/S, Valby, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Safety Pharmacology, H. Lundbeck A/S, Valby, Copenhagen, Denmark","institution_ids":["https://openalex.org/I133593841"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007712662","display_name":"Andrew Harkin","orcid":"https://orcid.org/0000-0001-9734-216X","observed_orcids":["https://orcid.org/0000-0001-9734-216X"]},"institutions":[{"id":"https://openalex.org/I27577105","display_name":"University College Cork","ror":"https://ror.org/03265fv13","country_code":"IE","type":"education","lineage":["https://openalex.org/I27577105"]}],"countries":["IE"],"is_corresponding":true,"raw_author_name":"Andrew Harkin","raw_affiliation_strings":["Department of Pharmacology and Therapeutics, School of Pharmacy, University College Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Therapeutics, School of Pharmacy, University College Cork, Ireland","institution_ids":["https://openalex.org/I27577105"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008675421","display_name":"Mark Maginn","orcid":"https://orcid.org/0009-0007-9035-7298","observed_orcids":["https://orcid.org/0009-0007-9035-7298"]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Mark Maginn","raw_affiliation_strings":["Department of Safety Pharmacology, H. Lundbeck A/S, Valby, Copenhagen, Denmark,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Safety Pharmacology, H. Lundbeck A/S, Valby, Copenhagen, Denmark,","institution_ids":["https://openalex.org/I133593841"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5007712662"],"corresponding_institution_ids":["https://openalex.org/I27577105"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":0.148,"has_fulltext":true,"cited_by_count":30,"citation_normalized_percentile":{"value":0.35155875,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"95","issue":"6","first_page":"299","last_page":"304"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9179999828338623,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9179999828338623,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11264","display_name":"Coffee research and impacts","score":0.07569999992847443,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adenosine-a1-receptor","display_name":"adenosine A1 receptor","score":0.8960000276565552},{"id":"https://openalex.org/keywords/caffeine","display_name":"caffeine","score":0.7730000019073486},{"id":"https://openalex.org/keywords/ethanol","display_name":"ethanol","score":0.9319999814033508},{"id":"https://openalex.org/keywords/motor-coordination","display_name":"motor coordination","score":0.8399999737739563},{"id":"https://openalex.org/keywords/adenosine-a2a-receptor","display_name":"adenosine A2A receptor","score":0.9240000247955322},{"id":"https://openalex.org/keywords/dpcpx","display_name":"DPCPX","score":0.9750000238418579},{"id":"https://openalex.org/keywords/sch58261","display_name":"SCH58261","score":0.9950000047683716},{"id":"https://openalex.org/keywords/ethanol-intoxication","display_name":"ethanol intoxication","score":0.6570000052452087},{"id":"https://openalex.org/keywords/adenosine-receptor-antagonists","display_name":"adenosine receptor antagonists","score":0.7649999856948853}],"concepts":[{"id":"https://openalex.org/C2778500429","wikidata":"https://www.wikidata.org/wiki/Q60235","display_name":"Caffeine","level":2,"score":0.9025650024414062},{"id":"https://openalex.org/C67907053","wikidata":"https://www.wikidata.org/wiki/Q356147","display_name":"Adenosine receptor","level":4,"score":0.7591778039932251},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7146342396736145},{"id":"https://openalex.org/C2780634109","wikidata":"https://www.wikidata.org/wiki/Q18350222","display_name":"Adenosine receptor antagonist","level":5,"score":0.702657163143158},{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.6784034967422485},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6044522523880005},{"id":"https://openalex.org/C2780161600","wikidata":"https://www.wikidata.org/wiki/Q153","display_name":"Ethanol","level":2,"score":0.5321321487426758},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5287627577781677},{"id":"https://openalex.org/C113062710","wikidata":"https://www.wikidata.org/wiki/Q2463100","display_name":"Motor coordination","level":2,"score":0.49711349606513977},{"id":"https://openalex.org/C182683403","wikidata":"https://www.wikidata.org/wiki/Q14888579","display_name":"Adenosine A1 receptor","level":5,"score":0.4385555386543274},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.43818432092666626},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3001036047935486},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.28623199462890625},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2698572278022766},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15450936555862427},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.10205167531967163},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000431","descriptor_name":"Ethanol","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D000431","descriptor_name":"Ethanol","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002110","descriptor_name":"Caffeine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002492","descriptor_name":"Central Nervous System Depressants","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D002492","descriptor_name":"Central Nervous System Depressants","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009048","descriptor_name":"Motor Skills","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014970","descriptor_name":"Xanthines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058915","descriptor_name":"Purinergic P1 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058916","descriptor_name":"Adenosine A1 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1742-7843.2004.pto950509.x","doi":"https://doi.org/10.1111/j.1742-7843.2004.pto950509.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1742-7843.2004.pto950509.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-7843.2004.pto950509.x","source":{"id":"https://openalex.org/S44074210","display_name":"Basic & Clinical Pharmacology & Toxicology","issn_l":"1742-7835","issn":["1742-7835","1742-7843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Basic &amp; Clinical Pharmacology &amp; Toxicology","raw_type":"journal-article"},{"id":"pmid:15569276","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15569276","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Basic & clinical pharmacology & toxicology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1742-7843.2004.pto950509.x","doi":"https://doi.org/10.1111/j.1742-7843.2004.pto950509.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1742-7843.2004.pto950509.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-7843.2004.pto950509.x","source":{"id":"https://openalex.org/S44074210","display_name":"Basic & Clinical Pharmacology & Toxicology","issn_l":"1742-7835","issn":["1742-7835","1742-7843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Basic &amp; Clinical Pharmacology &amp; Toxicology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320312041","display_name":"Health Research Board","ror":"https://ror.org/003hb2249"},{"id":"https://openalex.org/F4320320863","display_name":"University College Cork","ror":"https://ror.org/03265fv13"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2139132107.pdf","grobid_xml":"https://content.openalex.org/works/W2139132107.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W13425038","https://openalex.org/W62524054","https://openalex.org/W1521659744","https://openalex.org/W1537234776","https://openalex.org/W1582008664","https://openalex.org/W1969170402","https://openalex.org/W1978093992","https://openalex.org/W1984975608","https://openalex.org/W2002933217","https://openalex.org/W2010921174","https://openalex.org/W2012553932","https://openalex.org/W2020773808","https://openalex.org/W2031500965","https://openalex.org/W2046349103","https://openalex.org/W2047963615","https://openalex.org/W2048146686","https://openalex.org/W2049000129","https://openalex.org/W2056124241","https://openalex.org/W2056209103","https://openalex.org/W2057411906","https://openalex.org/W2060207467","https://openalex.org/W2061473590","https://openalex.org/W2065906875","https://openalex.org/W2066733291","https://openalex.org/W2067467266","https://openalex.org/W2076129331","https://openalex.org/W2077798545","https://openalex.org/W2083822913","https://openalex.org/W2092410453","https://openalex.org/W2093169784","https://openalex.org/W2123936855","https://openalex.org/W2134633991","https://openalex.org/W2136717001","https://openalex.org/W2138416809","https://openalex.org/W2145758516","https://openalex.org/W2162149701","https://openalex.org/W4244984044","https://openalex.org/W4245759787","https://openalex.org/W4414004094"],"related_works":["https://openalex.org/W2162149701","https://openalex.org/W3141971733","https://openalex.org/W2123936855","https://openalex.org/W2047963615","https://openalex.org/W2092903946","https://openalex.org/W2079562583","https://openalex.org/W2067467266","https://openalex.org/W2048146686","https://openalex.org/W2101826020","https://openalex.org/W1983424615"],"abstract_inverted_index":{"The":[0],"effects":[1],"of":[2,4,14,32,67,103,134,146,154],"co-administration":[3],"caffeine":[5,33,58,135,147],"and":[6,35,70,140],"ethanol":[7,93],"were":[8],"assessed":[9],"on":[10,16,28,117,136],"the":[11,17,29,55,65,83,104,118,131,144,150],"motor":[12,26,52,77,97,120,138],"coordination":[13],"rats":[15],"accelerating":[18],"rotarod":[19],"(accelerod).":[20],"Ethanol":[21],"(2.5":[22,94],"g/kg,":[23,95],"orally)":[24,38,47],"decreased":[25],"performance":[27,53],"accelerod.":[30],"Co-administration":[31],"(5":[34,89],"20":[36],"mg/kg,":[37,46,90],"dose-dependently":[39],"attenuated":[40,92],"this":[41],"ethanol-induced":[42,76,119,137],"deficit.":[43,121],"Caffeine":[44],"(20":[45],"alone":[48],"did":[49],"not":[50],"affect":[51],"in":[54],"test.":[56],"As":[57],"is":[59],"a":[60],"non-selective":[61],"adenosine":[62,68,84,105,126],"receptor":[63,72,86,128],"antagonist":[64,87,108],"ability":[66,145],"A(1)":[69,85,127],"A(2A)":[71,106],"blockade":[73,129],"to":[74,143,148],"attenuate":[75],"incoordination":[78],"was":[79],"determined.":[80],"Pre-treatment":[81],"with":[82],"DPCPX":[88],"intraperitoneally)":[91,113],"orally)-induced":[96],"incoordination.":[98],"By":[99],"contrast,":[100],"prior":[101],"administration":[102],"selective":[107],"SCH":[109],"58261":[110],"(10":[111],"mg/kg":[112],"had":[114],"no":[115],"effect":[116],"These":[122],"data":[123],"demonstrate":[124],"that":[125],"mimics":[130],"inhibitory":[132],"action":[133],"incorordination,":[139],"may":[141],"contribute":[142],"offset":[149],"acute":[151],"intoxicating":[152],"actions":[153],"ethanol.":[155]},"counts_by_year":[{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
